Physical Therapy in Pregnant Women With Preeclampsia
FPE
Influence of a Physical Therapy Protocol in Maternal and Fetal Hemodynamics in Pregnant Women With Preeclampsia
2 other identifiers
interventional
60
1 country
1
Brief Summary
The aim of this study is to evaluate the influence that has a physical therapy protocol in maternal and fetal hemodynamics in relation to blood pressure, maternal and fetal responses and perinatal outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Jun 2012
Shorter than P25 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 25, 2012
CompletedFirst Posted
Study publicly available on registry
June 28, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2013
CompletedJune 28, 2012
June 1, 2012
7 months
June 25, 2012
June 27, 2012
Conditions
Keywords
Interventions
Physical therapy in women with preeclampsia during the hospitalization
Comparison of maternal and fetal hemodynamics in women with preeclampsia who underwent physical therapy and who did not have physical therapy
Eligibility Criteria
You may qualify if:
- Participed of The study, high-risk pregnant women with gestational age between 24 and 38 weeks, hospitalized with a diagnosis of preeclampsia or chronic hypertension with superimposed preeclampsia, with no other maternal diseases and absence of fetal diseases by diagnostic ultrasound examinations and fetal well.
You may not qualify if:
- Pregnant women who became symptomatic (blurred vision, epigastric pain, headache) secondary to the hypertensive process;
- hour proteinuria above 2 g
- Laboratory abnormalities (thrombocytopenia, alteration of renal function, elevated liver enzymes, elevated bilirubin);
- Request the patient to leave the project.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Hospital Clinics, University of Sao Paulo
Ribeirão Preto, São Paulo, 14049-900, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- physiotherapist graduate student in biology of reproduction
Study Record Dates
First Submitted
June 25, 2012
First Posted
June 28, 2012
Study Start
June 1, 2012
Primary Completion
January 1, 2013
Study Completion
February 1, 2013
Last Updated
June 28, 2012
Record last verified: 2012-06